Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy

Our novel antibiotic use denominator, targeted antimicrobial use admission, is defined as an inpatient admission in which a select agent or group of agents is administered. Used in combination with length of therapy, it allows programs to quickly assess agent inpatient durations.